Ocular Surface Changes in Primary Open Angle Glaucoma Patients Treated With Topical Antihypertensive Drugs

被引:2
|
作者
Castro, Catarina [1 ,4 ]
Marta, Ana [1 ,2 ]
Marques, Joao H. [1 ]
Ferreira, Andre [1 ,3 ]
Jose, Diana [1 ]
Sousa, Paulo [1 ]
Neves, Isabel [1 ]
Meneres, Maria Joao [1 ,2 ]
Barbosa, Irene [1 ,2 ]
机构
[1] Univ Porto, Ctr Hosp Univ St Antonio, Dept Ophthalmol, Porto, Portugal
[2] Univ Porto, Inst Biomed Sci Abel Salazar, Dept Ophthalmol, Porto, Portugal
[3] Univ Porto, Dept Biomed, Unit Anat, Fac Med, Porto, Portugal
[4] Ctr Hosp Univ Porto, Dept Ophthalmol, P-4099001 Porto, Portugal
关键词
glaucoma; ocular surface; dry eye disease; QUALITY-OF-LIFE; DRY EYE SYNDROME; INTRAOCULAR-PRESSURE; DISEASE;
D O I
10.1097/IJG.0000000000002272
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Precis: In this study, patients with glaucoma undergoing topical antihypertensive (TAH) drugs had changes in the ocular surface and more dry eye symptoms than controls. Clinicians should recognize the influence of TAH drops on exacerbating ocular surface disease.Purpose: The purpose of this study was to evaluate the ocular surface of eyes with glaucoma treated with TAH drugs.Methods: Cross-sectional study that included eyes undergoing TAH drugs due to primary open angle glaucoma and controls. The parameters evaluated were: the basal tear flow (basic secretion test); the tear film osmolarity (TearLab); and the noninvasive break-up time, blink score, lipid layer thickness, tear meniscus height, and loss area of the meibomian glands, measured with the IDRA Ocular Surface Analyser. Presence of symptoms [Ocular Surface Disease Index (OSDI)], dry eye disease (DED, TFOS DEWS II criteria), and corneal fluorescein staining were assessed.Results: We included 154 eyes (154 patients), 77 undergoing TAH drugs for glaucoma (group 1) and 77 of controls (group 2). The tear film osmolarity (P=0.003) and the loss area of the meibomian glands (P=0.004) were higher in group 1. The noninvasive break-up time (P=0.005), lipid layer thickness (P=0.006), and tear meniscus height (P=0.001) were lower in group 1. The global OSDI score (P<0.001), the proportion of eyes with severe disease (P=0.002), according to the OSDI, and with DED (P<0.001), according to the TFOS DEWS II criteria, were higher in group 1. The proportion of patients with corneal fluorescein staining was higher in group 1 (P<0.001). There were no significant differences in eyes taking TAH drugs with and without preservatives (P>0.127).Conclusions: DED, in patients with glaucoma, is a multifactorial disease, with a strong contribution from TAH drugs. These eyes had changes in almost every measured parameter, translating into the presence of more dry eye symptoms and corneal damage when compared with controls.
引用
收藏
页码:E113 / E120
页数:8
相关论文
共 50 条
  • [21] Spectral analysis of intraocular pressure pulse wave in ocular hypertensive and primary open angle glaucoma patients
    Bozic, Marija M.
    Dukic, Miroslav L.
    Stojkovic, Milenko Z.
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2016, 64 (02) : 114 - 117
  • [22] Apoptosis in the iris and trabecular meshwork of medically treated and untreated primary open angle glaucoma patients
    Aktas, Zeynep
    Karaca, Emine Esra
    Gonul, Ipek Isik
    Hasanreisoglu, Murat
    Onol, Merih
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2013, 6 (06) : 827 - 830
  • [23] Bimatoprost/timolol fixed combination(BTFC) in patients with primary open angle glaucoma or ocular hypertension in Greece
    Tryfon G.Rotsos
    Vasso G.Kliafa
    Kevin J.Asher
    Dimitrios Papaconstantinou
    International Journal of Ophthalmology, 2016, 9 (01) : 69 - 75
  • [24] Discomfort during instillation of antihypertensives and ocular surface condition in glaucoma patients
    Dorofeev, Dmitry A.
    Antonov, Alexey A.
    Gorobets, Aleksandr, V
    Kirilik, Elena, V
    Safronova, Alexandra K.
    Sinitsky, Anton, I
    Pozdeeva, Olga G.
    Shatrova, Yuliya M.
    Tsyganov, Artem Z.
    RUSSIAN OPEN MEDICAL JOURNAL, 2022, 11 (04)
  • [25] Quality of life of patients with primary open-angle glaucoma, primary angle closure glaucoma, and pseudoexfoliation glaucoma in Central Serbia
    Marceta, Elizabeta
    Vulovic, Tatjana Sarenac
    Petrovic, Nenad
    Vulovic, Dejan
    Trenkic, Marija
    Randjelovic, Danijela
    Todorovic, Dusan
    VOJNOSANITETSKI PREGLED, 2023, 80 (10) : 852 - 859
  • [26] Evaluation of the lamina cribrosa after topical latanoprost therapy in primary open-angle glaucoma or ocular hypertension
    Duru, Zeynep
    Gundogan, Medine
    Sert, Ibrahim
    Isin, Numan
    Atas, Mustafa
    Sirakaya, Ender
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2024, 48
  • [27] Efficacy and Tolerability of Topical 0.05% Flunarizine in Patients With Open-angle Glaucoma or Ocular Hypertension-A Pilot Study
    Mansouri, Kaweh
    Silva, Sergio Estrela
    Shaarawy, Tarek
    JOURNAL OF GLAUCOMA, 2011, 20 (08) : 519 - 522
  • [28] Central corneal thickness in primary open angle glaucoma, pseudoexfoliative glaucoma, ocular hypertension, and normal population
    Yagci, R
    Eksioglu, U
    Midillioglu, I
    Yalvac, I
    Altiparmak, E
    Duman, S
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2005, 15 (03) : 324 - 328
  • [29] Bimatoprost 0.01 % for previously treated patients with open-angle glaucoma or ocular hypertension in the Korean clinical setting
    Kook, Michael Scott
    Simonyi, Susan
    Sohn, Yong Ho
    Kim, Chan Yun
    Park, Ki Ho
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2015, 59 (05) : 325 - 334
  • [30] Evaluation of the Efficacy Duration of Topical Therapies in Eyes with Primary Open-Angle Glaucoma
    Lanza, Michele
    Leone, Angelo
    Scognamiglio, Gabriele
    Serra, Luigi
    Iodice, Clemente Maria
    Melillo, Paolo
    Simonelli, Francesca
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (20)